Am. J. Respir. Crit. Care Med., Vol 153, No. 3, Mar 1996, 936-941.
A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients
M Ichinose, M Miura, H Yamauchi, N Kageyama, M Tomaki, T Oyake, Y Ohuchi, W Hida, H Miki, G Tamura and K Shirato
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Recent reports suggest the involvement of vascular phenomena in
exercise-induced asthma. Sensory neuropeptides, such as substance P (SP),
which causes airway vascular dilatation and plasma leakage, have been
demonstrated to play a role in hyperpnea-induced airway narrowing in animal
studies. The purpose of this study was to investigate the importance of
tachykinins in exercise-induced airway narrowing in patients with asthma
using a selective neurokinin 1-receptor (NK1- receptor) antagonist, FK-888.
In a double-blind, placebo-controlled, crossover trial, nine subjects with
stable asthma were given FK-888 (2.5 mg) or placebo by inhalation 20 min
before each exercise at a level previously demonstrated to cause a fall of
at least 40% in specific airway conduction (SGaw). Inhalation of FK-888 had
no significant effect on baseline SGaw. While the recovery from exercise-
induced airway narrowing was significantly faster after treatment with
FK-888 the area under the curve for SGaw during the 50 min after exercise
was significantly reduced (p<0.05) and the time taken for the SGaw to
recover to within 65% of baseline after exercise was also significantly
shorter with FK-888 than the placebo (p<0.05). However, treatment with
FK-888 did not significantly attenuate the maximal fall in SGaw. These
results suggest that NK1-receptor-mediated mechanisms are involved in the
recovery phase of exercise-induced airway narrowing. The possible
mechanisms of these phenomena are discussed.
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Joachim, V. Sagach, D. Quarcoo, Q. T. Dinh, P. C. Arck, and B. F. Klapp
Neurokinin-1 Receptor Mediates Stress-Exacerbated Allergic Airway Inflammation and Airway Hyperresponsiveness in Mice
Psychosom Med,
July 1, 2004;
66(4):
564 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.F. Joos and B. O'Connor
Indirect airway challenges
Eur. Respir. J.,
June 1, 2003;
21(6):
1050 - 1068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. JOOS, K. O. DE SWERT, V. SCHELFHOUT, and R. A. PAUWELS
The Role of Neural Inflammation in Asthma and Chronic Obstructive Pulmonary Disease
Ann. N.Y. Acad. Sci.,
May 1, 2003;
992(1):
218 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Freed, S. McCulloch, T. Meyers, and R. Suzuki
Neurokinins Modulate Hyperventilation-induced Bronchoconstriction in Canine Peripheral Airways
Am. J. Respir. Crit. Care Med.,
April 15, 2003;
167(8):
1102 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa, K. Asai, K. Hirata, and J. Yoshikawa
Vascular Involvement in Exercise-Induced Airway Narrowing in Patients With Bronchial Asthma*
Chest,
July 1, 2002;
122(1):
166 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. MAGHNI, R. TAHA, W. AFIF, Q. HAMID, and J. G. MARTIN
Dichotomy between Neurokinin Receptor Actions in Modulating Allergic Airway Responses in an Animal Model of Helper T Cell Type 2 Cytokine-associated Inflammation
Am. J. Respir. Crit. Care Med.,
September 1, 2000;
162(3):
1068 - 1074.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Mhanna, I. A. Dreshaj, M. A. Haxhiu, and R. J. Martin
Mechanism for substance P-induced relaxation of precontracted airway smooth muscle during development
Am J Physiol Lung Cell Mol Physiol,
January 1, 1999;
276(1):
L51 - L56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev.,
December 1, 1998;
50(4):
515 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|